Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
16.66 +0.29 / +1.77%
As of 1:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.66 0.00 / 0.00%
Volume: 5.1K

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +62.06% increase from the last price of 16.66.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -22.91%
Growthannually -34.38%


Growthquarterly 11.42%
Growthannually 18.55%
Key to the earnings and sales forecast charts.